Medication Use and Drug Expenditure in Inflammatory Bowel Disease: based on Korean National Health Insurance Claims Data (2010-2014) |
Ha, Jung Eun
(College of Pharmacy, CHA University)
Jang, Eun Jin (College of Natural Sciences, Andong National University) Im, Seul Gi (College of Natural Sciences, Kyungpook National University) Sohn, Hyun Soon (College of Pharmacy, CHA University) |
1 | Shin DH, Sinn DH, Kim YH, et al. Increasing incidence of inflammatory bowel disease among young men in Korea between 2003 and 2008. Dig Dis Sci 2011;56:1154-9. DOI |
2 | Lee KM and Lee JM. Crohn's disease in Korea: past, present, and future. Korean J Intern Med 2014;29:558-70. DOI |
3 | Choi CH, Moon W, Kim YS, et al. IBD Study Group of the Korean Association for the Study of the Intestinal Diseases. Second Korean Guideline for the Management of Ulcerative Colitis. Korean J Gastroenterol 2017;69(1):1-28. DOI |
4 | Dignass A, Van Assche G, Lindsay JO, et al. The second European evidence-based consensus on the diagnosis and management of Crohn's disease: current management. J Crohns Colitis 2010;4:28-62. DOI |
5 | Peyrin-Biroulet L, Sandborn W, Sands BE, et al. Selecting therapeutic targets in inflammatory bowel disease (STRIDE): determining therapeutic goals for treat-to-target. Am J Gastroenterol 2015;110:1324-38. DOI |
6 | Choi CH, Kim YH, Kim YS, et al. IBD Study Group of the Korean Association for the Study of Intestinal Diseases. Guidelines for the management of ulcerative colitis. Korean J Gastroenterol 2012;59(2):118-40. DOI |
7 | Choi CH, Moon W, Kim YS, et al. IBD Study Group of the Korean Association for the Study of Intestinal Diseases. Second Korean guidelines for the management of ulcerative colitis. Intest Res 2017;15(1):7-37. DOI |
8 | Ye BD, Yang SK, Shin SJ, et al. IBD Study Group of the Korean Association for the Study of the Intestinal Diseases. Guidelines for the management of Crohn's disease. Korean J Gastroenterol 2012;59(2):141-79. DOI |
9 | Park JJ, Yang SK, Ye BD, et al. IBD Study Group of the Korean Association for the Study of Intestinal Diseases. Second Korean guidelines for the management of Crohn's disease. Intest Res 2017;15(1):38-67. DOI |
10 | Statistics Korea. Korean Standard Classification of Diseases (KCD)-7 code. 2016. Korean Standard Statistical Classification. Available at https://kssc.kostat.go.kr:8443/ksscNew_web/kssc/main/main.do?gubun=1#. Accessed Feb 18, 2018. |
11 | Heath Insurance Review & Assessment Service. National Drug Formulary List. Available at http://www.hira.or.kr/bbsDummy.do?pgmid=HIRAA030014050000. Accessed Dec 15, 2015. |
12 | Ye BD, Han DS, Youn EJ, et al. The clinical features and prognosis of Crohn's disease: a Korean multicenter nationwide cohort study In: 9th Congress of European Crohn's and Colitis Organization; 2014 Feb 20-22. Copenhagen. Vienna: ECCO, 2014;8(Suppl 1):S315. |
13 | Kim HJ, Hann HJ, Hong SN, et al. Incidence and natural course of inflammatory bowel disease in Korea, 2006-2012: a nationwide population-based study. Inflamm Bowel Dis 2015;21:623-30. DOI |
14 | Kim JW, Lee CK, Rhee SY, Oh CH, Shim JJ, Kim HJ. Trends in health-care costs and utilization for inflammatory bowel disease from 2010 to 2014 in Korea: A nationwide population-based study. J Gastroenterol Hepatol 2017 Oct 21. doi: 10.1111/jgh.14027. [Epub ahead of print] DOI |
15 | Yang SK, Yun S, Kim JH, et al. Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005: a KASID study. Inflamm Bowel Dis 2008;14:542-9. DOI |
16 | Kuo CJ, Yu KH, See LC. The trend of inflammatory bowel diseases in Taiwan: a population-based study. Dig Dis Sci 2015;60(8):2454-62. DOI |
17 | Park SH, Yang SK, Park SK, et al. Long-term prognosis of Crohn's disease and its temporal change between 1981 and 2012: a hospitalbased cohort study from Korea. Inflamm Bowel Dis 2014;20:488-94. DOI |
18 | Moon CM, Park DI, Kim ER, et al. Clinical features and predictors of clinical outcomes in Korean patients with Crohn's disease: a Korean association for the study of intestinal diseases multicenter study. J Gastroenterol Hepatol 2014;29:74-82. DOI |
19 | Solberg IC, Vatn MH, Hoie O, et al. Clinical course in Crohn's disease: results of a Norwegian population-based ten-year follow-up study. Clin Gastroenterol Hepatol 2007;5:1430-8. DOI |
20 | Cosnes J, Cattan S, Blain A, et al. Long-term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis 2002;8:244-50. DOI |
21 | Ministry of Health Welfare. Standard for calculating the deductible for the applicant. MOHW Notice No. 2017-171. 2017.9.26. National Law Information Center. Available at http://www.law.go.kr. Accessed Feb 17, 2018. |
22 | Kaplan GG and Ng SC. Understanding and preventing the global increase of inflammatory bowel disease. Gastroenterology 2017;152:313-21. DOI |
23 | Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet 2017;390:2769-78. DOI |
24 | Wei SC, Lin MH, Tung CC, et al. A nationwide population-based study of the inflammatory bowel diseases between 1998 and 2008 in Taiwan. BMC Gastroenterol 2013;13:166. DOI |
25 | Vegh Z, Kurti Z, Lakatos PL. Epidemiology of inflammatory bowel disease from west to east. J Dig Dis 2017;18(2):92-8. DOI |
26 | Ng WK, Wong SH, Ng SC. Changing epidemiological trends of inflammatory bowel disease in Asia. Intest Res 2016;14(2):111-9. DOI |
27 | Prideaux L, Kamm MA, De Cruz PP, Chan FK, Ng SC. Inflammatory bowel disease in Asia: a systematic review. J Gastroenterol Hepatol 2012;27(8):1266-80. DOI |
28 | Ng SC, Tang W, Ching JY, et al. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study. Gastroenterology 2013;145:158-65. DOI |
29 | Park SJ, Kim WH, Cheon JH. Clinical characteristics and treatment of inflammatory bowel disease: a comparison of Eastern and Western perspectives. World J Gastroenterol 2014;20(33):11525-37. DOI |